Commercial licensing opportunities currently exist for:
USA, Canada, Middle East, Asia and Africa.
Worldwide
Alfa – Crohn’s disease – Inflammatory Bowel Disease (IBD)
Alfa – Familial Adenomatous Polyposis (FAP)
All countries except France, Germany, Italy, Spain and the UK.
Contact
Head Office
UK Office
Ground Floor, Building 6
Leavesden Park
Hercules Way
WD25 7GS
United Kingdom
T / +44 1923 681001